The notices it replaced
- Reissues: PAR-18-427 First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01-Clinical Trial Required)
- 2 steps back: PAR-17-327 First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01)
- 3 steps back: PAR-14-107 First in Human and Early Stage Clinical Trials of Novel Investigational Drugs for Psychiatric Disorders (U01)
- 4 steps back: PAR-12-007 Innovative Pilot Studies of Novel Mechanism of Action Compounds for Treating Psychiatric Disorders (U01)
- 5 steps back: PAR-11-316 Innovative Pilot Studies of Novel Mechanism of Action Compounds for Treating Psychiatric Disorders (U01)
Replaced by PAR-25-180.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,440,701 in first-year total cost, median $729,032.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-B (01)]2
- Special Emphasis Panel[ZMH1 ERB-L (05)]2
- Special Emphasis Panel[ZMH1 ERB-D (04)]1
- Special Emphasis Panel[ZMH1 ERB-S (03)]1
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- JOHNS HOPKINS UNIVERSITY1
- OCEAN STATE RESEARCH INSTITUTE, INC.1
- OHIO STATE UNIVERSITY1
- UNIVERSITY OF NEBRASKA MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Use of alpha-frequency deep transcranial interference stimulation (tIS) to understand and modify temporal dynamics of face emotion recognition and social/affective function.1U01MH135436-01 | JAVITT, DANIEL C.JUCHEM, CHRISTOPHSEHATPOUR, PEJMAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $1,045,140 | ZMH1 |
| 2023 | Deep Brain Stimulation for Chronic Auditory Hallucinations in Treatment-Resistant Schizophrenia: an early-stage clinical trial1U01MH130625-01A1 | CASCELLA, NICOLA G | JOHNS HOPKINS UNIVERSITY, MD | $794,858 | ZMH1 |
| 2022 | Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial1U01MH128483-01 · under PAR-18-427 | LENZE, ERIC JPALANCA, BEN JULIAN | WASHINGTON UNIVERSITY, MO | $703,237 | ZMH1 |
| 2022 | Magnetic Resonance-guided Focused Ultrasound Ablation of the Anterior Thalamus as a Novel Treatment Paradigm for Anxiety1U01MH128677-01 · under PAR-18-427 | LUCAS, TIMOTHY HPHAN, K. LUAN | OHIO STATE UNIVERSITY, OH | $532,134 | ZMH1 |
| 2021 | Low intensity focused ultrasound: a new paradigm for depression and anxiety1U01MH123427-01A1 · under PAR-18-427 | PHILIP, NOAH STEPHEN | OCEAN STATE RESEARCH INSTITUTE, INC., RI | $610,506 | ZMH1 |
| 2020 | Dose-Response Relationship and Pharmacokinetics of Intranasal Oxytocin on Neural Impact in Youths with High Levels of Irritability1U01MH120155-01A1 · under PAR-18-427 | HWANG, SOONJOSHAFFER, CHRISTOPHER LEE | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $754,826 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.